Adaptimmune Therapeutics PLC (NASDAQ:ADAP)
| 1.63 Delayed Data As of May 20 |  -0.04 / -2.40%Today’s Change | 1.26 Today|||52-Week Range 6.86 | -56.53% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 16.8M | 14.1M | 38.2M | 59.4M | |
| Depreciation And Amortization | 2.5M | 3.3M | 5.5M | 7.8M | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 70.0M | 83.1M | 123.9M | 150.9M | ||
| Research And Development | 50.2M | 63.3M | 98.1M | 115.2M | ||
| Total Operating Expenses | 72.5M | 86.4M | 129.4M | 158.7M | ||
| Non-Operating Expenses | Operating Income | -55.7M | -72.3M | -91.1M | -99.3M | |
| Extraordinary Charge | 0.00 | 0.00 | -1.0M | -209.6K | ||
| Other Expenses | 2.8M | 995.1K | 8.6M | -15.5M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -26.2M | -70.2M | -81.3M | -112.1M | |
| Income Taxes | -3.8M | -885.8K | -10.4M | -16.8M | ||
| Net Income | -22.4M | -71.1M | -70.9M | -95.4M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 70.8M | 70.8M | 87.9M | 97.4M | |
| Shares To Calculate EPS Diluted | 70.8M | 70.8M | 87.9M | 97.4M | ||
| Earnings Per Share | EPS | -$0.18 | -$1.01 | -$0.79 | -$0.98 | |
| EPS Diluted | -$0.27 | -$1.01 | -$0.79 | -$0.98 | ||
